You are here » Home » Companies » Company Overview » Shivalik Rasayan Ltd

Shivalik Rasayan Ltd.

BSE: 539148 Sector: Agri and agri inputs
NSE: SHIVALIK ISIN Code: INE788J01021
BSE 12:34 | 16 Aug 804.90 2.30
(0.29%)
OPEN

801.25

HIGH

804.95

LOW

789.50

NSE 12:24 | 16 Aug 802.00
(%)
OPEN

799.50

HIGH

812.20

LOW

788.80

OPEN 801.25
PREVIOUS CLOSE 802.60
VOLUME 146
52-Week high 1196.80
52-Week low 661.05
P/E 60.61
Mkt Cap.(Rs cr) 1,166
Buy Price 801.35
Buy Qty 1.00
Sell Price 804.50
Sell Qty 1.00
OPEN 801.25
CLOSE 802.60
VOLUME 146
52-Week high 1196.80
52-Week low 661.05
P/E 60.61
Mkt Cap.(Rs cr) 1,166
Buy Price 801.35
Buy Qty 1.00
Sell Price 804.50
Sell Qty 1.00

Shivalik Rasayan Ltd. (SHIVALIK) - Company History

Shivalik Rasayan Limited was registered with the ROC Gwalior Madhya Pradesh dated 16 March 1979. The company shifted its registered office from Madhya Pradesh to Uttar Pradesh in February 231980. The Company is manufacturer of organophosphate insecticides such as Dimethoate Technical and Malathion Technical.During the year 2016 the Company acquired 44.12% equity shares of M/s Medicamen Biotech Limited in accordance with the Share Purchase Agreement with Promoters of M/s Medicamen Biotech Limited. The company took over the full management control in Medicamen Biotech Limited on 1st January 2016. M/s Medicamen Biotech Limited is a Pharmaceutical manufacturing company having its manufacturing facilities at Bhiwadi (Rajasthan) and Haridwar (Uttarkhand).During FY2017-18 the company increased paid up capital from Rs.34200000/- divided into 3420000 equity shares of Rs 10/- each to Rs 42080000/- divided into 4208000 equity shares of Rs 10/- each by issuing 788000 convertible warrants into equity shares on preferential basis to promoter group and Non-promoter group.During the year 2018-19 the Company sub-divided its equity shares having face value of Rs. 10/- each into 2 fully paid-up Equity Shares having face value of Rs. 5/- each. Further the Company allotted 2104000 equity shares as fully paid-up bonus shares in the ratio of 1:4 to its shareholders on April 23 2018 pursuant to a resolution passed by the shareholders on April 10 2018 through postal ballot.

.